Life Science Reagents

STEMCELL Technologies develops specialized cell culture media, cell isolation products, reagents, and instruments for life sciences research, including cell therapy and drug discovery. Their ethically sourced human primary cells from peripheral blood, cord blood, and bone marrow support fundamental and translational research. With over 2500 products like cGMP-compliant media, differentiation kits, and cryopreservation solutions, they enable scalable workflows for T cell therapies, hematopoietic cells, and pluripotent stem cell applications.

SWISSCI provides innovative laboratory solutions for crystallography, Cryo EM, cell culture, data collection, and PCR applications in life sciences and pharma R&D. They manufacture specialized products including MRC 2-well and 3-well crystallization plates, glass bottom optical assay plates for imaging, hanging drop seals, and no-centrifuge ultrafiltration devices. These tools support protein crystallization, sample concentration, and high-clarity imaging with reduced autofluorescence.

QIAGEN offers OEM and custom manufacturing solutions for life sciences and pharma, including bulk production of enzymes, oligos, buffers, kits, assays, and automation systems. With over 40 years of experience, they provide scalable, high-quality products from prototype to commercial scale through ISO and GMP-certified global facilities. Strategic partnerships enable rapid market entry while ensuring compliance, quality, and consistency.

Sekisui Diagnostics develops, manufactures, and supplies clinical chemistry reagents, point-of-care tests, and pre-analytic systems for laboratories, hospitals, and healthcare providers worldwide. Their portfolio includes over 65 reagents for cardiovascular, diabetes, renal, and infectious disease testing, alongside rapid antigen and molecular tests like OSOM and Metrix for COVID-19, influenza, and respiratory health. They also provide specialty enzymes and materials for biotherapeutic manufacture, pharmaceutical production, and diagnostic reagents to support R&D and scale-up processes.

Sapio Sciences offers a science-aware lab informatics platform combining LIMS, ELN, and SDMS to support biotech, pharma, and diagnostics labs in research, development, and manufacturing. Key capabilities include AI-powered assistants like ELaiN, immunogenicity and GMP workflows, chemistry and molecular biology tools, and multimodal entity registration for small- and large-molecule discovery. The platform enables lab automation, data integration, and workflow management across in vivo studies, bioanalysis, and bioprocessing.

IsoPlexis provides single-cell multiplexed proteomics platforms that enable simultaneous detection of 40+ proteins secreted from individual immune cells. Their IsoCode chip and IsoLight system allow pharmaceutical and biotech companies to characterize cellular functional heterogeneity for precision medicine applications in cancer immunology, cell and gene therapy, and infectious disease. The technology delivers patient-specific biomarker insights that traditional bulk analysis cannot capture, supporting personalized treatment selection and immunotherapy patient profiling.

Quantum-Si offers benchtop proteomics platforms for single-molecule protein sequencing, enabling real-time analysis in research labs. Their Platinum and upcoming Proteus systems provide next-generation performance for biomarker discovery and therapeutic development. Key advancements include detection of up to 20 amino acids and controlled cleavage chemistry for billions of sequencing reads.

Nautilus Biotechnology pioneers single-molecule proteome analysis through its Voyager Platform, designed to measure up to 10 billion intact proteins and proteoforms simultaneously in a single run. The platform delivers accurate quantification with unprecedented dynamic range across the entire proteome, enabling pharmaceutical and research organizations to generate deep biological insights for drug discovery, biomarker identification, and disease research. Using proprietary Iterative Mapping technology and machine-learning powered analysis, the benchtop instrument requires no special lab facilities and provides reproducible, digital protein counts suitable for AI workflows.

Sino Biological is an internationally recognized reagent supplier and contract research organization specializing in recombinant protein production and antibody development. The company offers over 6,000 recombinant proteins and 13,000 antibodies, produced using its proprietary mammalian cell-based expression system for high-efficiency antigen and antibody manufacturing. Headquartered in Beijing with subsidiaries in the United States and Europe, its products support virology, infectious disease research, and applications like SARS-CoV-2 diagnostics with FDA EUA approvals.

Tozaro designs and develops non-biological affinity reagents and smart polymers for cell and gene therapy bioprocessing. The company provides synthetic antibody alternatives for viral vector analytics, purification, and characterization, enabling greater control and insight beyond traditional biological reagents. Tozaro's rationally designed polymers are created using computational chemistry and can be delivered within two weeks of target specification.

SomaLogic offers the SomaScan Assay, a high-plex proteomics platform measuring over 7,000 proteins simultaneously from small plasma or serum samples with high sensitivity, specificity, and reproducibility. It supports biomarker discovery, drug development, diagnostics, and clinical testing for cardiovascular risk, cancer, and other diseases. Now part of Illumina, it enables multiomics insights for pharmaceutical R&D and health management.

SomaLogic provides advanced proteomics technology that measures approximately 7,000 proteins simultaneously from small biological samples, enabling biomarker discovery, diagnostics development, and drug discovery. The company's SomaScan Platform offers high specificity, sensitivity, and reproducibility, and is now part of Illumina following their acquisition. SomaLogic serves academic institutions, biopharmaceutical researchers, and clinical applications through its SomaSignal Tests for disease risk assessment and health monitoring.

ProteoNic BioSciences offers proprietary vector technologies like 2G UNic™ to pharmaceutical, biotech, and CDMO companies for enhancing protein production, viral vector titers, and gene expression in mammalian, yeast, and fungal cells. The technology optimizes mRNA translation, boosts yields for complex proteins such as multi-specific antibodies, and lowers production costs through non-exclusive worldwide licensing. Validated across common expression platforms, it supports biologics and gene therapy manufacturing with customization options.

Spear Bio offers SPEAR UltraDetect, a homogeneous immunoassay platform for ultrasensitive protein biomarker detection using patented two-factor authentication and qPCR amplification. It enables attomolar sensitivity from 1 µL samples, targeting neurology biomarkers like pTau231, pTau217, GFAP, and NfL for neurodegenerative disease research. The technology supports research-use-only applications with services for custom assay development and biomarker analysis.

Sphere Bio provides picodroplet microfluidic instruments, consumables, and reagents for high-throughput single cell analysis, isolation, and monoclonality assurance. Their flagship Cyto-Mine Chroma platform screens up to 40 million cells per day for applications in antibody discovery, cell line development, cell therapy, and synthetic biology. As a Fluidic Sciences brand, they support biopharma R&D with integrated workflows for rapid screening of viable, high-producing clones.

Takara Bio provides kits, reagents, instruments, and services for life science research in gene discovery, regulation, function, cancer therapy, NGS, and single-cell technologies. The company offers CDMO services for regenerative medicine, including GMP manufacturing for cellular and gene therapy products at facilities in Japan, the US, Europe, China, and India. Their portfolio supports applications like CAR-T therapy, immune profiling, vaccine development, and drug discovery.

Life Technologies, now part of Thermo Fisher Scientific, provides innovative technologies and solutions for life sciences, including reagents, instruments, and software for genomics, proteomics, cell biology, and molecular diagnostics. It supports pharmaceutical R&D in drug development, genetic research, personalized medicine, and bioproduction with products like DNA sequencing systems, cell culture media, and PCR reagents. The company serves global customers in over 160 countries, focusing on accelerating research and improving laboratory productivity.

Twist Bioscience provides synthetic DNA products including genes, oligo pools, NGS tools, and antibody libraries for pharmaceutical R&D and drug discovery. Their proprietary silicon-based platform enables high-throughput, cost-effective DNA synthesis up to 5kb genes with rapid turnaround. They support pre-clinical studies with research-grade plasmid preps and biopharma solutions for antibody optimization.

AltaBioscience offers custom peptide synthesis, DNA oligos, polyclonal and monoclonal antibodies, plus analytical services like amino acid analysis, protein sequencing, and mass spectrometry from its UK-based ISO 9001:2015 laboratory. Protein sequencing and amino acid analysis are accredited to ISO 17025:2017 standards. The company serves pharmaceutical, academic, healthcare, and food industry clients globally with high-quality biochemical products and expertise established since 1973.

Vector Laboratories manufactures high-quality reagents for immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation, supporting protein labeling, detection, and visualization in life sciences research. The company offers custom manufacturing services, including recombinant antibody engineering and bioconjugate development, serving biopharma, academia, and life science tools companies worldwide. With over 45 years of expertise and global facilities, Vector empowers advances in cancer research, neuroscience, immunology, and infectious disease.

Veloxity Labs is a bioanalytical CRO specializing in LC-MS/MS analysis for small molecules, peptides, and proteins from discovery through GLP/GCP-regulated clinical studies. They offer high-sensitivity methods, microsampling technology, and proprietary AI-powered automation (VELO™) to accelerate drug development while adhering to GLP, GCP, and ICH M10 standards. Based in Peoria, Illinois, their 48,000 sq. ft. facility supports both regulated and non-regulated testing, with recent acquisition of the SCIEX ZenoTOF 8600 system enhancing peptide and complex bioanalysis.